Search Results - "Rackauskas, M."

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    A case report of a lung transplant recipient receiving belatacept in combination with low dose tacrolimus complicated by progressive multifocal leukoencephalopathy by C, Vahdatpour, B, Saha, M, Younis, C, Montuoro, I, Timofte, M, Rackauskas, A, Emtiazjoo

    Published in Respiratory medicine case reports (01-01-2024)
    “…Belatacept is a novel T-cell costimulation blockade agent that has unresolved controversy in lung transplant recipients. Belatacept has been recognized as a…”
    Get full text
    Journal Article
  2. 2

    Left cardiac sympathetic denervation: case series and technical report by McNamara, C., Cullen, P., Rackauskas, M., Kelly, R., O’Sullivan, K. E., Galvin, J., Eaton, D.

    Published in Irish journal of medical science (01-08-2017)
    “…Background Left cardiac sympathetic denervation (LCSD) is a surgical procedure that has been shown to have an antiarrhythmic and antifibrillatory effect…”
    Get full text
    Journal Article
  3. 3
  4. 4

    (1268) Administration of Exogenous Bmp9 Ameliorates Lung Transplant Ischemia Reperfusion Injury by Gill, B., Tu, Z., Langerude, L., Nord, D., Emtiazjoo, A., Rackauskas, M., Atkinson, C.

    “…Primary graft dysfunction (PGD) is a severe form of acute lung injury that is a major cause of early morbidity and mortality encountered after lung…”
    Get full text
    Journal Article
  5. 5

    (1269) Increased Circulating Cell Junction Proteins are Associated with the Development of Primary Graft Dysfunction by Nord, D., Langerude, L., Gill, B., Moussa, H., Emtiazjoo, A., Shahmohammadi, A., Rackauskas, M., Atkinson, C.

    “…Dysfunction of epithelial and endothelial cellular junctions can lead to a decline in alveolar-capillary barrier function, the loss of which can lead to…”
    Get full text
    Journal Article
  6. 6
  7. 7
  8. 8

    Does Belatacept Provide a Safe Renal Sparing Immunosuppression in Lung Transplant Recipients? A Single-Center Experience by Benn, L., inger, Chizinga, M., Scheuble, V., Nandavaram, S., Shahmohammadi, A., Pipkin, M., Rackauskas, M., Machuca, T.N., Alnuaimat, H., Lin, C.M., Emtiazjoo, A., Pelaez, A., Chandrashekaran, S.

    “…Belatacept reduces calcineurin inhibitor (CNI) nephrotoxicity in kidney transplant recipients. However, its use in lung transplantation is extremely limited…”
    Get full text
    Journal Article
  9. 9

    Optimizing Short Stature Patients Access to Transplantation through Surgical Downsizing of Donor Lungs by Pruitt, E.Y., Gerber, M., Pipkin, M., Neal, D., Scheuble, V., Rackauskas, M., Shahmohammadi, A., Chandrashekaran, S., Emtiazjoo, A., Alnuaimat, H., Sharma, A., Palaez, A., Machuca, T.

    “…Due to donor/recipient size matching challenges, lung transplant candidates height may pose a significant disadvantage for receiving a transplant, resulting in…”
    Get full text
    Journal Article
  10. 10

    Interferon-beta (IFNb) Reprograms Pathogenic Lung Dendritic Cells in Human Chronic Lung Allograft Dysfunction (CLAD) by Emtiazjoo, A.M., Mansouri, S., Katikaneni, D., Pelaez, A., Chandrashekaran, S., Shahmohammadi, A., Nandavaram, S., Lin, C., Alnuaimat, H., Scheuble, V., Rackauskas, M., Pipkin, M., Machuca, T., Jin, L.

    “…Dendritic cells (DC) are central to the induction and maintenance of T regulatory cells (T-regs) and lung allograft tolerance. We previously identified tumor…”
    Get full text
    Journal Article
  11. 11

    Perioperative Desensitization for Sensitized Lung Transplant Candidates by Nandavaram, S., Shahmohammadi, A., Chandrashekaran, S., Emtiazjoo, A., Alnuaimat, H., Lin, C., Benninger, L., Scheuble, V., Pipkin, M., Rackauskas, M., Machuca, T., Pelaez, A.

    “…Sensitized lung transplant (LTx) candidates have longer waiting times, decreased likelihood of transplant, and increased risk of death while on waitlist. To…”
    Get full text
    Journal Article
  12. 12
  13. 13
  14. 14

    A case report of a lung transplant recipient receiving belatacept in combination with low dose tacrolimus complicated by progressive multifocal leukoencephalopathy by C, Vahdatpour, B, Saha, M, Younis, C, Montuoro, I, Timofte, M, Rackauskas, A, Emtiazjoo

    Published in Respiratory medicine case reports (01-01-2024)
    “…Belatacept is a novel T-cell costimulation blockade agent that has unresolved controversy in lung transplant recipients. Belatacept has been recognized as a…”
    Get full text
    Report
  15. 15
  16. 16